Christine M. Lovly, M.D., Ph.D., is associate professor of medicine within the Division of Hematology and Oncology at Vanderbilt University School of Medicine and co-leader of the Translational Research and Interventional Oncology (TRIO) program at Vanderbilt Ingram Cancer Center. She specializes in the treatment of lung cancer, and her research interests involve mechanistic studies aimed at understanding molecular mechanisms of response and resistance to anti-cancer agents.
